Aethlon Medical (AEMD) Cash from Financing Activities (2010 - 2026)
Aethlon Medical's (AEMD) quarterly Cash from Financing Activities came in at -$196496.0 in Q1 2026, down 108.33% YoY from $2.4 million in Q1 2025, and down 106.59% on a QoQ basis from $3.0 million in Q4 2025.
Aethlon Medical (AEMD) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Aethlon Medical (AEMD) has 17 years of Cash from Financing Activities data on file, last reported at -$196496.0 in Q1 2026.
- Quarterly Cash from Financing Activities fell 108.33% year-over-year to -$196496.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.5 million (down 15.6% YoY) and the FY2026 annual result came in at $6.5 million, down 15.6% from the prior year.
- Cash from Financing Activities fell to -$196496.0 in Q1 2026, from $3.0 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $8.3 million in Q3 2022 to a low of -$196496.0 in Q1 2026.
- A 5-year average of $1.4 million and a median of $42572.0 in 2024 frame the typical range for Cash from Financing Activities.
- Annual changes were most pronounced in 2025 — Cash from Financing Activities surged 97728.44% — and 2026, when it tumbled 108.33%.
- Tracing AEMD's Cash from Financing Activities over 5 years: stood at -$1884.0 in 2022, then jumped by 9501.75% to $177129.0 in 2023, then sank by 103.99% to -$7073.0 in 2024, then jumped by 42269.31% to $3.0 million in 2025, then sank by 106.59% to -$196496.0 in 2026.
- The last three Cash from Financing Activities figures came in at -$196496.0 (Q1 2026), $3.0 million (Q4 2025), and $3.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Aethlon Medical | 1.04 Mn | 1.04 Mn | - | 1.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.82 Mn |
| Jun 30, 2026 | 1.82 Mn |
| Mar 31, 2026 | -196,496.00 |
| Mar 31, 2026 | -196,496.00 |
| Dec 31, 2025 | 2.98 Mn |
| Dec 31, 2025 | 2.98 Mn |
| Sep 30, 2025 | 3.74 Mn |
| Sep 30, 2025 | 3.74 Mn |
| Jun 30, 2025 | -5,357.00 |
| Jun 30, 2025 | -5,357.00 |
| Mar 31, 2025 | 2.36 Mn |
| Mar 31, 2025 | 2.36 Mn |
| Dec 31, 2024 | -7,073.00 |
| Dec 31, 2024 | -7,073.00 |
| Sep 30, 2024 | -3,832.00 |
| Sep 30, 2024 | -3,832.00 |
| Jun 30, 2024 | 5.38 Mn |
| Jun 30, 2024 | 5.38 Mn |
| Mar 31, 2024 | 42,572.00 |
| Mar 31, 2024 | 42,572.00 |